Patents by Inventor Yingxin Zhao

Yingxin Zhao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230400046
    Abstract: A quick-detachable connecting device with a simplified thread structure includes a top nozzle, a connecting tube sleeve, a locking tube and a locking piece. The top nozzle is provided with a through hole, in which the connecting tube sleeve is assembled. The locking tube is accommodated in the through hole. An outer peripheral surface of the locking tube is provided with a second stopping structure, and an inner peripheral surface of the connecting tube sleeve is provided with a first stopping structure fitting the second stopping structure. The locking piece is movably arranged on the locking tube for circumferentially limiting or releasing the locking tube. A connection method using such connecting device is also provided.
    Type: Application
    Filed: August 24, 2023
    Publication date: December 14, 2023
    Inventors: Wenqiang LI, Yingdong LIU, Hai XIANG, Jiahao CHEN, Yingxin ZHAO, Jiawei WANG
  • Patent number: 11828324
    Abstract: A quick-detachable connecting device with a simplified thread structure includes a top nozzle, a connecting tube sleeve, a locking tube and a locking piece. The top nozzle is provided with a through hole, in which the connecting tube sleeve is assembled. The locking tube is accommodated in the through hole. An outer peripheral surface of the locking tube is provided with a second stopping structure, and an inner peripheral surface of the connecting tube sleeve is provided with a first stopping structure fitting the second stopping structure. The locking piece is movably arranged on the locking tube for circumferentially limiting or releasing the locking tube. A connection method using such connecting device is also provided.
    Type: Grant
    Filed: August 24, 2023
    Date of Patent: November 28, 2023
    Assignee: Sichuan University
    Inventors: Wenqiang Li, Yingdong Liu, Hai Xiang, Jiahao Chen, Yingxin Zhao, Jiawei Wang
  • Publication number: 20210063394
    Abstract: Certain embodiments are directed to detection methods and methods of identifying detection targets for sensitive and specific laboratory tests to diagnose and monitor rickettsial infections during the earliest stages of the disease and to assess the degree of illness.
    Type: Application
    Filed: August 27, 2020
    Publication date: March 4, 2021
    Applicant: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Allan R. BRASIER, Yingxin ZHAO, David H. WALKER, Rong FANG
  • Patent number: 9834770
    Abstract: DNA aptamers are high affinity ligands selected by genetic enrichment techniques to bind to specific protein targets. Because these represent chemically stable and reproducible molecules, they have application as affinity reagents and/or therapeutic drugs to affect the target protein's actions. NF-kB is an important mediator of the innate immune response and mediator of tissue inflammation. Although RNA and double stranded DNA aptamers have been identified to bind to the NF-kB family of proteins, the present invention represents the first identification of single stranded DNA aptamers that recognize NFkB RelA. The aptamers disclosed herein bind to several distinct regions of RelA and may be useful to antagonize the DNA binding of RelA as an inhibitor of cellular inflammation, visualize the location or amount of RelA in tissues from pathological conditions, or to quantitatively measure the activated state of RelA by affinity binding.
    Type: Grant
    Filed: March 30, 2015
    Date of Patent: December 5, 2017
    Assignee: Board of Regents, The University of Texas System
    Inventors: Steven G. Widen, Thomas G. Wood, Allan R. Brasier, Yingxin Zhao
  • Publication number: 20150259687
    Abstract: DNA aptamers are high affinity ligands selected by genetic enrichment techniques to bind to specific protein targets. Because these represent chemically stable and reproducible molecules, they have application as affinity reagents and/or therapeutic drugs to affect the target protein's actions. NF-kB is an important mediator of the innate immune response and mediator of tissue inflammation. Although RNA and double stranded DNA aptamers have been identified to bind to the NF-kB family of proteins, the present invention represents the first identification of single stranded DNA aptamers that recognize NFkB RelA. The aptamers disclosed herein bind to several distinct regions of RelA and may be useful to antagonize the DNA binding of RelA as an inhibitor of cellular inflammation, visualize the location or amount of RelA in tissues from pathological conditions, or to quantitatively measure the activated state of RelA by affinity binding.
    Type: Application
    Filed: March 30, 2015
    Publication date: September 17, 2015
    Inventors: Steven G. Widen, Thomas G. Wood, Allan R. Brasier, Yingxin Zhao
  • Patent number: 9018367
    Abstract: DNA aptamers are high affinity ligands selected by genetic enrichment techniques to bind to specific protein targets. Because these represent chemically stable and reproducible molecules, they have application as affinity reagents and/or therapeutic drugs to affect the target protein's actions. NF-kB is an important mediator of the innate immune response and mediator of tissue inflammation. Although RNA and double stranded DNA aptamers have been identified to bind to the NF-kB family of proteins, the present invention represents the first identification of single stranded DNA aptamers that recognize NFkB RelA. The aptamers disclosed herein bind to several distinct regions of RelA and may be useful to antagonize the DNA binding of RelA as an inhibitor of cellular inflammation, visualize the location or amount of RelA in tissues from pathological conditions, or to quantitatively measure the activated state of RelA by affinity binding.
    Type: Grant
    Filed: April 12, 2012
    Date of Patent: April 28, 2015
    Assignee: Board of Regents, The University of Texas System
    Inventors: Steven G. Widen, Thomas G. Wood, Allan R. Brasier, Yingxin Zhao
  • Publication number: 20120263651
    Abstract: DNA aptamers are high affinity ligands selected by genetic enrichment techniques to bind to specific protein targets. Because these represent chemically stable and reproducible molecules, they have application as affinity reagents and/or therapeutic drugs to affect the target protein's actions. NF-kB is an important mediator of the innate immune response and mediator of tissue inflammation. Although RNA and double stranded DNA aptamers have been identified to bind to the NF-kB family of proteins, the present invention represents the first identification of single stranded DNA aptamers that recognize NFkB RelA. The aptamers disclosed herein bind to several distinct regions of RelA and may be useful to antagonize the DNA binding of RelA as an inhibitor of cellular inflammation, visualize the location or amount of RelA in tissues from pathological conditions, or to quantitatively measure the activated state of RelA by affinity binding.
    Type: Application
    Filed: April 12, 2012
    Publication date: October 18, 2012
    Applicant: Board of Regents, The University of Texas System
    Inventors: Steven G. Widen, Thomas G. Wood, Allan R. Brasier, Yingxin Zhao